Powered by MOMENTUM MEDIA
defence connect logo

Website Notifications

Get notifications in real-time for staying up to date with content that matters to you.

Medical Countermeasures Program takes next steps

dmtc mcp round

Three projects have been selected to progress under round two of the Defence Materials Technology Centre’s (DMTC) Medical Countermeasure Program.

Three projects have been selected to progress under round two of the Defence Materials Technology Centre’s (DMTC) Medical Countermeasure Program.

Minister for Defence Industry Christopher Pyne said more than 50 expressions of interest were received from across Australia, and that the three successful projects will share around $5 million worth of funding under the program.

Advertisement
Advertisement

Projects from Flinders Unviersity, in partnership with the Australian Respiratory & Sleep Medicine Institute and Vaxine Pty Ltd; the University of Queensland; and Planet Innovation, with its research partners from CSIRO, were revealed as the successful projects.

"Flinders University, the Australian Respiratory & Sleep Medicine Institute and Adelaide-based SME Vaxine Pty Ltd will work collaboratively to advance the work on vaccines against Japanese encephalitis and related viruses," Minister Pyne said.

"The University of Queensland will lead the development of magnetic nanotechnologies that will assist with the administration of anti-biotics by speeding up the diagnosis of microbial infections.

"Planet Innovation and research partners from CSIRO will partner on a project to further develop a deployable, point of care diagnostic system that can track outbreaks as they happen in real time, minimising the spread of disease."

Minister Pyne said the projects received technical expertise and support from industry and research partners as part of the program.

PROMOTED CONTENT

"That in itself is a great reflection of the dual purpose of the DMTC – to enhance Defence capabilities but also to strengthen the industrial sector supporting Defence," the minister said.

"These projects are a step forward in reducing Australia’s reliance on imported medical countermeasures products.

"Medical countermeasures are an important sovereign capability for military or civilian personnel in a range of scenarios, including biological warfare or chemical attacks, as well as the potential spread of global infectious disease pandemics."

This round of projects has been supported by funding from CSIRO and the Defence Science and Technology Group through its Next Generation Technologies Fund.

The DMTC is a key partner for the Defence Innovation Hub. Launched in 2016, the hub will invest around $640 million over the decade in maturing and further developing technologies that have moved from the early science stages into the engineering and development stages.

Medical Countermeasures Program takes next steps
DMTC-MCP-Round-2.jpg
lawyersweekly logo

more from defence connect

Jun 29 2022
Marles concedes ‘extremely optimistic’ 2030 SSN delivery
The Defence Minister has acknowledged the Royal Australian Navy is unlikely to assume ownership of a nuclear-powered submarine bef...
Jun 29 2022
Boeing opens new distribution centre in Brisbane
The global defence and aerospace giant has bolstered investment in Australia’s sovereign aviation capabilities with the unveilin...
Jun 29 2022
How award winner used life lessons for academic success
As Defence Connect prepares to host the 2022 Australian Defence Industry Awards, BAE Systems Australia’s Brett Smith recalls how...